Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 2
1966 1
1967 1
1968 2
1969 1
1970 2
1971 1
1972 1
1973 4
1974 5
1975 3
1976 8
1977 2
1978 5
1980 6
1981 6
1982 4
1983 9
1984 5
1985 6
1986 8
1987 13
1988 20
1989 40
1990 26
1991 37
1992 29
1993 31
1994 23
1995 39
1996 32
1997 36
1998 29
1999 26
2000 56
2001 33
2002 49
2003 53
2004 55
2005 66
2006 54
2007 46
2008 43
2009 62
2010 54
2011 76
2012 58
2013 54
2014 44
2015 65
2016 50
2017 69
2018 71
2019 47
2020 50
2021 61
2022 58
2023 60
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

1,690 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop.
Bilezikian JP, Khan AA, Silverberg SJ, Fuleihan GE, Marcocci C, Minisola S, Perrier N, Sitges-Serra A, Thakker RV, Guyatt G, Mannstadt M, Potts JT, Clarke BL, Brandi ML; International Workshop on Primary Hyperparathyroidism. Bilezikian JP, et al. J Bone Miner Res. 2022 Nov;37(11):2293-2314. doi: 10.1002/jbmr.4677. Epub 2022 Oct 17. J Bone Miner Res. 2022. PMID: 36245251 Free article. Review.
The last international guidelines on the evaluation and management of primary hyperparathyroidism (PHPT) were published in 2014. Research since that time has led to new insights into epidemiology, pathophysiology, diagnosis, measurements, genetics, outcomes, present …
The last international guidelines on the evaluation and management of primary hyperparathyroidism (PHPT) were published in 201 …
Hypercalcemia: A Review.
Walker MD, Shane E. Walker MD, et al. JAMA. 2022 Oct 25;328(16):1624-1636. doi: 10.1001/jama.2022.18331. JAMA. 2022. PMID: 36282253 Review.
OBSERVATIONS: Approximately 90% of people with hypercalcemia have primary hyperparathyroidism (PHPT) or malignancy. Additional causes of hypercalcemia include granulomatous disease such as sarcoidosis, endocrinopathies such as thyroid disease, immobilization, geneti …
OBSERVATIONS: Approximately 90% of people with hypercalcemia have primary hyperparathyroidism (PHPT) or malignancy. Additional …
Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.
Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young JE, Rejnmark L, Thakker R, D'Amour P, Paul T, Van Uum S, Shrayyef MZ, Goltzman D, Kaiser S, Cusano NE, Bouillon R, Mosekilde L, Kung AW, Rao SD, Bhadada SK, Clarke BL, Liu J, Duh Q, Lewiecki EM, Bandeira F, Eastell R, Marcocci C, Silverberg SJ, Udelsman R, Davison KS, Potts JT Jr, Brandi ML, Bilezikian JP. Khan AA, et al. Osteoporos Int. 2017 Jan;28(1):1-19. doi: 10.1007/s00198-016-3716-2. Epub 2016 Sep 9. Osteoporos Int. 2017. PMID: 27613721 Free PMC article. Review.
The purpose of this review is to assess the most recent evidence in the management of primary hyperparathyroidism (PHPT) and provide updated recommendations for its evaluation, diagnosis and treatment. A Medline search of "Hyperparathyroidism. Primary" …
The purpose of this review is to assess the most recent evidence in the management of primary hyperparathyroidism (PHPT) and p …
Epidemiology, Pathophysiology, and Genetics of Primary Hyperparathyroidism.
Minisola S, Arnold A, Belaya Z, Brandi ML, Clarke BL, Hannan FM, Hofbauer LC, Insogna KL, Lacroix A, Liberman U, Palermo A, Pepe J, Rizzoli R, Wermers R, Thakker RV. Minisola S, et al. J Bone Miner Res. 2022 Nov;37(11):2315-2329. doi: 10.1002/jbmr.4665. Epub 2022 Oct 17. J Bone Miner Res. 2022. PMID: 36245271 Free PMC article. Review.
In this narrative review, we present data gathered over four decades (1980-2020) on the epidemiology, pathophysiology and genetics of primary hyperparathyroidism (PHPT). PHPT is typically a disease of postmenopausal women, but its prevalence and incidence vary globa …
In this narrative review, we present data gathered over four decades (1980-2020) on the epidemiology, pathophysiology and genetics of pri
Normocalcemic primary hyperparathyroidism.
Cusano NE, Cetani F. Cusano NE, et al. Arch Endocrinol Metab. 2022 Nov 11;66(5):666-677. doi: 10.20945/2359-3997000000556. Arch Endocrinol Metab. 2022. PMID: 36382756 Free PMC article. Review.
Normocalcemic primary hyperparathyroidism (PHPT) is a newer phenotype of PHPT defined by elevated PTH concentrations in the setting of normal serum calcium levels. ...A diagnosis of normocalcemic disease is one of exclusion of secondary forms of hyperparathyroidi
Normocalcemic primary hyperparathyroidism (PHPT) is a newer phenotype of PHPT defined by elevated PTH concentrations in the se …
Primary hyperparathyroidism.
Kowalski GJ, Buła G, Żądło D, Gawrychowska A, Gawrychowski J. Kowalski GJ, et al. Endokrynol Pol. 2020;71(3):260-270. doi: 10.5603/EP.a2020.0028. Endokrynol Pol. 2020. PMID: 32797471 Free article. Review.
Primary hyperparathyroidism is an endocrine disorder that results in overproduction of parathyroid hormone by overactivated parathyroid gland leading to a significant rise in blood serum calcium. It results in hypercalcaemia, which has a significant impact mainly on
Primary hyperparathyroidism is an endocrine disorder that results in overproduction of parathyroid hormone by overactivated pa
Hyperparathyroidism.
Bilezikian JP, Bandeira L, Khan A, Cusano NE. Bilezikian JP, et al. Lancet. 2018 Jan 13;391(10116):168-178. doi: 10.1016/S0140-6736(17)31430-7. Epub 2017 Sep 17. Lancet. 2018. PMID: 28923463 Review.
Primary hyperparathyroidism is a common endocrine disorder of calcium metabolism characterised by hypercalcaemia and elevated or inappropriately normal concentrations of parathyroid hormone. ...In countries where biochemical screening tests are not common, symptomat
Primary hyperparathyroidism is a common endocrine disorder of calcium metabolism characterised by hypercalcaemia and elevated
Primary hyperparathyroidism.
Muñoz-Torres M, García-Martín A. Muñoz-Torres M, et al. Med Clin (Barc). 2018 Mar 23;150(6):226-232. doi: 10.1016/j.medcli.2017.07.020. Epub 2017 Oct 6. Med Clin (Barc). 2018. PMID: 28992983 Review. English, Spanish.
Primary hyperparathyroidism (PHPT) is a common endocrinological process, characterized by chronic elevation of serum concentrations of calcium and parathyroid hormone (PTH). ...
Primary hyperparathyroidism (PHPT) is a common endocrinological process, characterized by chronic elevation of serum concentra
Primary hyperparathyroidism.
Walker MD, Silverberg SJ. Walker MD, et al. Nat Rev Endocrinol. 2018 Feb;14(2):115-125. doi: 10.1038/nrendo.2017.104. Epub 2017 Sep 8. Nat Rev Endocrinol. 2018. PMID: 28885621 Free PMC article. Review.
In this Review, we describe the pathogenesis, diagnosis and management of primary hyperparathyroidism (PHPT), with a focus on recent advances in the field. ...
In this Review, we describe the pathogenesis, diagnosis and management of primary hyperparathyroidism (PHPT), with a focus on …
Primary Hyperparathyroidism.
Bilezikian JP. Bilezikian JP. J Clin Endocrinol Metab. 2018 Nov 1;103(11):3993-4004. doi: 10.1210/jc.2018-01225. J Clin Endocrinol Metab. 2018. PMID: 30060226 Free PMC article. Review.
BACKGROUND: Primary hyperparathyroidism (PHPT), the most common cause of hypercalcemia, is most often identified in postmenopausal women. ...
BACKGROUND: Primary hyperparathyroidism (PHPT), the most common cause of hypercalcemia, is most often identified in postmenopa …
1,690 results